Report Forecasts Proteomics Market at $2.68B in 2008
A new study forecasts that the proteomics market will grow to $2.68 billion in 2008, from $1.52 billion in 2003— a less bold projection than that of a report by the same firm in 2001.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.
Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.
In Nature this week: paternal age associated with de novo mutations in children, and more.
Nature News writes that researchers are still wrangling over the role of the p-value.
This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.